Organometallic Ligands
In this category, you will be able to find a large number of organometallic molecules used as ligands in biomolecules. These organometallic ligands can be used in organic chemistry and synthesis in the laboratory. They play a critical role in forming coordination complexes and catalyzing various chemical reactions. At CymitQuimica, we offer a diverse selection of high-quality organometallic ligands to support your research and industrial needs.
Subcategories of "Organometallic Ligands"
BIMAH
BINAP
BINOL
BPE
Buchwald Ligands
Cyclic Alkyl Amino Carbenes (CAAC)
DANPHOS
DUPHOS
Jacobsen Ligands
Phosphine
Photocatalyst Ligands
Pincer Ligands and Complexes
Polyisobutylene (PIB) Ligands and Complexes
Porphirines
Pybox
Show 7 more subcategories
Products of "Organometallic Ligands"
[S(R)]-N-[(R)-(3,5-Di-tert-butyl-4-methoxyphenyl)[2-(diphenylphosphino)-4,5-dimethoxyphenyl]-2-methyl-2-propanesulfinamide, 95%
Ref: 08-15-8364
50mg | Discontinued | Request information |
2,2-Bis[(4S)-4-tert-butyl-2-oxazolin-2-yl]propane, min. 98%
Ref: 08-07-0003
1g | Discontinued | Request information | |
250mg | Discontinued | Request information |
2-[(4S)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]-pyrimidine, min. 95%
Ref: 08-07-0017
100mg | Discontinued | Request information |
2,2-Bis((3aS,8aR)-3a,8a-dihydro-8H-indeno[1,2-d]oxazol-2-yl)acetonitrile, min. 98%
Ref: 08-07-0014
100mg | Discontinued | Request information |
[S(R)]-N-[(S)-(3,5-Dimethylphenyl)[2-(diphenylphosphino)phenyl]methyl]-N,2-dimethyl-2-propanesulfinamide, 95%
Ref: 08-15-8769
50mg | Discontinued | Request information |
(3aS,3a'S,8aR,8a'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole], 98%, (99% ee)
Ref: 08-07-1404
50mg | Discontinued | Request information |
1-[(4R)-4,5-Dihydro-4-isopropyl-2-oxazolyl]isoquinoline, 98%, (99% ee)
Ref: 08-07-1368
100mg | Discontinued | Request information |
[S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-N,2-dimethyl-2-propanesulfinamide, 95%
Ref: 08-15-8336
50mg | Discontinued | Request information |
[S(R)]-N-[(1S)-1-[3',5'-Bis(1,1-dimethylethyl)-4'-methoxy[1,1'-biphenyl]-2-yl]-2-(diphenylphosphino)ethyl]-2-methyl-2-propanesulfinamide, 95%
Ref: 08-15-8372
50mg | Discontinued | Request information |
[S(R)]-N-((1S)-1-(2-(Dicyclohexylphosphino)phenyl)ethyl)-2-methyl-2-propanesulfinamide, 95%
Ref: 08-15-8787
50mg | Discontinued | Request information |
(4R,4'R)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole), 98%
Ref: 08-07-1088
25mg | Discontinued | Request information | |
100mg | Discontinued | Request information |
[S(R)]-N-[(S)-(4-(tert-Butyl)phenyl)[2-(dicyclohexylphosphino)phenyl]methyl]-2-methyl-2-propanesulfinamide, 95%
Ref: 08-15-8798
50mg | Discontinued | Request information |
(4R,4'R)-2,2'-Cyclohexylidenebis[4-tert-butyl-4,5-dihydrooxazole], 98%, (99% ee)
Ref: 08-07-1392
50mg | Discontinued | Request information |
(4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-isopropyloxazole], 98%, (99% ee)
Ref: 08-07-1434
100mg | Discontinued | Request information |
[S(R)]-N-[(R)-[6-(Diphenylphosphino)benzo[d][1,3]dioxol-5-yl]-1-naphthalenylmethyl]-2-methyl-2-propanesulfinamide, 95%
Ref: 08-15-8354
50mg | Discontinued | Request information |
[S(R)]-N-((S)-(2-(Diphenylphosphino)phenyl)(2,4,6-triisopropylphenyl)methyl)-2-methyl-2-propanesulfinamide, 95%
Ref: 08-15-8778
50mg | Discontinued | Request information |
[S(R)]-N-((R)-(2-(Diphenylphosphino)phenyl)(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)methyl]-2-methyl-2-propanesulfinamide, 95%
Ref: 08-15-8736
50mg | Discontinued | Request information |
(S)-3-Isopropyl-2,5-piperazinedione, min. 98%
Ref: 08-07-0002
1g | Discontinued | Request information | |
5g | Discontinued | Request information |
[S(R)]-N-[(1S)-1-[2-(Diphenylphosphino)phenyl]-2,2-dimethylpropyl]-2-methyl-2-propanesulfinamide, 95%
Ref: 08-15-8328
100mg | Discontinued | Request information |
[S(R)]-N-[(R)-[6-(Diphenylphosphino)benzo[d][1,3]dioxol-5-yl]phenylmethyl]-2-methyl-2-propanesulfinamide, 95%
Ref: 08-15-8352
50mg | Discontinued | Request information |